Skip to main content
TipRanks
Go Ultimate75% OFF

TG Therapeutics (NKB2) Q2 2026 Earnings Report

0 Followers

CH:NKB2 Q2 2026 EPS Results

Actual EPS
CHF 0.04
Consensus EPS
CHF 0.25
Beat/Miss
Missed by -CHF 0.21
One Year Ago EPS
CHF 0.14

CH:NKB2 Q2 2026 Revenue Results

Actual Revenue
CHF 198.38M
Expected Revenue
CHF 189.66M
Beat/Miss
Beat by +CHF 8.72M
YoY Revenue Growth
+70.27%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/03/2026
Time
Before Open
Conference Call
Monday, August 3, 2026
CH:NKB2 Upcoming Earnings

TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CH:NKB2 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:NKB2 Earnings History

CH:NKB2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)0.43-0.12――
Nov 09, 20262026 (Q3)0.300.292.01-85.60% (-1.72)
Aug 03, 20262026 (Q2)0.250.040.14-70.59% (-0.10)
May 06, 20262026 (Q1)0.230.100.02300.00% (+0.07)
Feb 26, 20262025 (Q4)0.290.120.12-6.67% (-0.01)
Nov 03, 20252025 (Q3)0.182.010.0212050.00% (+1.99)
Aug 04, 20252025 (Q2)0.170.140.03325.00% (+0.11)
May 05, 20252025 (Q1)0.140.02-0.06142.86% (+0.08)
Mar 03, 20252024 (Q4)0.130.12-0.07266.67% (+0.20)
Nov 04, 20242024 (Q3)0.020.020.6-97.26% (-0.59)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed